Vanderkarr, Mari F.
Ruppenkamp, Jill W.
Vanderkarr, Mollie
Holy, Chantal E.
Blauth, Michael
Funding for this research was provided by:
Johnson & Johnson
Article History
Received: 17 July 2023
Accepted: 21 September 2023
First Online: 3 October 2023
Declarations
:
: All data in the MarketScan<sup>®</sup> database being de-identified, the use of these data for this study is exempt from Institutional Review Board oversight as dictated by Title 45 Code of Federal Regulations, Part 46 of the USA, specifically 45 CFR 46.101(b)[CitationRef removed]. All methods were conducted in accordance with relevant guidelines and regulations. Experimental protocols were drafted and approved by all co-authors and the MedTech Epidemiology research team within Johnson & Johnson, prior to the conduct of the study.
: Not applicable—no identifiable patient-level data are included in this publication.
: MFV, JWR and CEH are employees of Johnson & Johnson. MV and MB are employees of DePuy Synthes, a Johnson & Johnson Company.